This collaboration ensures that patients receive comprehensive care, including emotional and psychological support throughout their fertility journey
The program will start with providing bTrastuzumab to cancer patients facing treatment delays due to budget constraints
BRAVE study will explore the potential of omaveloxolone to address the critical unmet need of the pediatric FA population
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
SUP will obtain regulatory approvals for selling Tiotropium DPI in China
The collaboration furthers AstraZeneca’s presence in China following the $2.5bn investment in Beijing
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
Now approved for both acute and chronic HCV in adults and children aged 3 and above
Conceptulised by Lowe Lintas, the new campaign creatively brings the "fast action" benefit of Cipladine to life through a series of films
This strategic expansion marks a significant step in the company's global growth strategy
Subscribe To Our Newsletter & Stay Updated
